Cargando…

Causal associations between disorders of lipoprotein metabolism and ten cardiovascular diseases

Disorders of lipoprotein metabolism have been linked with an increased risk of cardiovascular diseases (CVDs) but the causal association is unclear. In this study, we investigated the causal association between disorders of lipoprotein metabolism and CVDs using two-sample Mendelian randomization (MR...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Qiannan, Tan, Jiang-Shan, Fan, Luyun, Wang, Xiaoqi, Hua, Lu, Cai, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593056/
https://www.ncbi.nlm.nih.gov/pubmed/36303606
http://dx.doi.org/10.3389/fcell.2022.1023006
_version_ 1784815072248332288
author Gao, Qiannan
Tan, Jiang-Shan
Fan, Luyun
Wang, Xiaoqi
Hua, Lu
Cai, Jun
author_facet Gao, Qiannan
Tan, Jiang-Shan
Fan, Luyun
Wang, Xiaoqi
Hua, Lu
Cai, Jun
author_sort Gao, Qiannan
collection PubMed
description Disorders of lipoprotein metabolism have been linked with an increased risk of cardiovascular diseases (CVDs) but the causal association is unclear. In this study, we investigated the causal association between disorders of lipoprotein metabolism and CVDs using two-sample Mendelian randomization (MR). The exposure was obtained from Finn genome-wide association studies (14,010 cases, 197,259 controls), and the corresponding CVDs were extracted from the largest published genome-wide association studies. A random-effects inverse-variance weighted method was used for the main analyses with a complementary analysis using the weighted median and MR-Egger approaches. Multiple sensitivity analyses were performed to assess horizontal pleiotropy. The MR analysis indicated positive associations of disorders of lipoprotein metabolism with coronary artery disease (odds ratio [OR] 1.670, 95% confidence interval [CI] 1.373–2.031; p < 0.001), aortic aneurysm (OR 1.394, 95% CI 1.199–1.619; p < 0.001), heart failure (OR 1.20, 95% CI 1.115–1.294; p < 0.001), hypertension (OR 1.011, 95% CI 1.006–1.091; p < 0.001), old myocardial infarction (OR 1.004, 95% CI 1.002–1.007; p = 0.001), and stroke (OR 1.002, 95% CI 1.001–1.003; p = 0.002). There is a suggestive causal relationship between disorders of lipoprotein metabolism and atrial fibrillation (OR 1.047, 95% CI 1.006–1.091; p = 0.026) and acute myocardial infarction (OR 1.003, 95% CI 1.001–1.005; p = 0.012). There was limited evidence of a causal association between disorders of lipoprotein metabolism and peripheral vascular disease and venous thromboembolism. Our findings indicate a significant causal association between disorders of lipoprotein metabolism and many CVDs, including coronary artery disease, aortic aneurysm, heart failure, hypertension, old myocardial infarction, and stroke. These associations may be useful for development of treatment strategies that regulate lipoprotein metabolism in patients with CVD.
format Online
Article
Text
id pubmed-9593056
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95930562022-10-26 Causal associations between disorders of lipoprotein metabolism and ten cardiovascular diseases Gao, Qiannan Tan, Jiang-Shan Fan, Luyun Wang, Xiaoqi Hua, Lu Cai, Jun Front Cell Dev Biol Cell and Developmental Biology Disorders of lipoprotein metabolism have been linked with an increased risk of cardiovascular diseases (CVDs) but the causal association is unclear. In this study, we investigated the causal association between disorders of lipoprotein metabolism and CVDs using two-sample Mendelian randomization (MR). The exposure was obtained from Finn genome-wide association studies (14,010 cases, 197,259 controls), and the corresponding CVDs were extracted from the largest published genome-wide association studies. A random-effects inverse-variance weighted method was used for the main analyses with a complementary analysis using the weighted median and MR-Egger approaches. Multiple sensitivity analyses were performed to assess horizontal pleiotropy. The MR analysis indicated positive associations of disorders of lipoprotein metabolism with coronary artery disease (odds ratio [OR] 1.670, 95% confidence interval [CI] 1.373–2.031; p < 0.001), aortic aneurysm (OR 1.394, 95% CI 1.199–1.619; p < 0.001), heart failure (OR 1.20, 95% CI 1.115–1.294; p < 0.001), hypertension (OR 1.011, 95% CI 1.006–1.091; p < 0.001), old myocardial infarction (OR 1.004, 95% CI 1.002–1.007; p = 0.001), and stroke (OR 1.002, 95% CI 1.001–1.003; p = 0.002). There is a suggestive causal relationship between disorders of lipoprotein metabolism and atrial fibrillation (OR 1.047, 95% CI 1.006–1.091; p = 0.026) and acute myocardial infarction (OR 1.003, 95% CI 1.001–1.005; p = 0.012). There was limited evidence of a causal association between disorders of lipoprotein metabolism and peripheral vascular disease and venous thromboembolism. Our findings indicate a significant causal association between disorders of lipoprotein metabolism and many CVDs, including coronary artery disease, aortic aneurysm, heart failure, hypertension, old myocardial infarction, and stroke. These associations may be useful for development of treatment strategies that regulate lipoprotein metabolism in patients with CVD. Frontiers Media S.A. 2022-10-11 /pmc/articles/PMC9593056/ /pubmed/36303606 http://dx.doi.org/10.3389/fcell.2022.1023006 Text en Copyright © 2022 Gao, Tan, Fan, Wang, Hua and Cai. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cell and Developmental Biology
Gao, Qiannan
Tan, Jiang-Shan
Fan, Luyun
Wang, Xiaoqi
Hua, Lu
Cai, Jun
Causal associations between disorders of lipoprotein metabolism and ten cardiovascular diseases
title Causal associations between disorders of lipoprotein metabolism and ten cardiovascular diseases
title_full Causal associations between disorders of lipoprotein metabolism and ten cardiovascular diseases
title_fullStr Causal associations between disorders of lipoprotein metabolism and ten cardiovascular diseases
title_full_unstemmed Causal associations between disorders of lipoprotein metabolism and ten cardiovascular diseases
title_short Causal associations between disorders of lipoprotein metabolism and ten cardiovascular diseases
title_sort causal associations between disorders of lipoprotein metabolism and ten cardiovascular diseases
topic Cell and Developmental Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593056/
https://www.ncbi.nlm.nih.gov/pubmed/36303606
http://dx.doi.org/10.3389/fcell.2022.1023006
work_keys_str_mv AT gaoqiannan causalassociationsbetweendisordersoflipoproteinmetabolismandtencardiovasculardiseases
AT tanjiangshan causalassociationsbetweendisordersoflipoproteinmetabolismandtencardiovasculardiseases
AT fanluyun causalassociationsbetweendisordersoflipoproteinmetabolismandtencardiovasculardiseases
AT wangxiaoqi causalassociationsbetweendisordersoflipoproteinmetabolismandtencardiovasculardiseases
AT hualu causalassociationsbetweendisordersoflipoproteinmetabolismandtencardiovasculardiseases
AT caijun causalassociationsbetweendisordersoflipoproteinmetabolismandtencardiovasculardiseases